Saturday, January 21, 2012
BMI May Be Flawed Measure Of Health.
The Boston Globe 
(1/7, Kotz) discussed why body mass index (BMI) may be a limited
measure of health, since "some people's weight and height measurements
put them in the overweight or even obese category while, in reality,
they are very lean and muscular. On the other hand, some people's BMI
indicates that they are healthy, when they are actually overfat, with
little lean tissue. So, whether or not your BMI indicates that you are
overweight, it is important to find out if you are carrying too much
body fat." Some experts believe "it's
worthwhile to have a body composition test once a year."
Group Issues Guideline For Hyperglycemia Management In Hospital Patients.
MedPage Today 
(1/6, Neal) reports, "All hospital patients should have blood glucose
levels measured on admission, according to an Endocrine Society clinical
practice guideline 
on managing hyperglycemia in non-critically ill patients" to appear in
the Journal of Clinical Endocrinology & Metabolism. "For most
patients with type 2 diabetes, the authors suggest discontinuation of
oral hypoglycemic agents and initiation of insulin therapy on admission
for an acute illness." This
recommendation "applies to both diabetic and normoglycemic patients, and
goes one step further than guidance from the American Diabetes
Association (ADA)," which "has recommended initial glucose measurements
for diabetic patients and nondiabetic patients who are receiving
therapies associated with hyperglycemia, with the recognition that high
blood glucose has been associated with a greater risk for complications
and death among hospitalized patients."
Hemodialysis Using Solar Power May Reduce Costs, Help Save Environment.
CBC News 
(1/6) reports that according to a study to appear Jan. 19 in the
Clinical Journal of the American Society of Nephrology, "using solar
power can make" hemodialysis "treatments more environmentally friendly."
For the study, "scientists created a solar-assisted dialysis program
in southern Australia. They set up four dialysis machines that ran
partially off solar power." Notably, "the program reduced power costs
by 76.5 per cent in the first 12 months."
Increased Gout Risk With Diuretic Use Confirmed
|
|||||||||
|
Action Points
Diuretics -- a class of drugs
known to raise serum urate levels -- independently increased the risk
for gout in patients with high blood pressure, a prospective cohort
study revealed.
After adjustment for blood pressure and potential confounders such as glomerular filtration rate, exposure to a diuretic led to a 1.48-fold increased likelihood of incident gout (95% CI 1.11 to 1.98), according to Mara A. McAdams DeMarco, PhD, of Johns Hopkins University in Baltimore, and colleagues. However, further adjustment for the level of serum urate nullified this association (HR 0.96, 95% CI 0.71 to 1.28), "suggesting that serum urate level may be a key intermediate on the pathway between diuretic use and incident gout," the researchers wrote in the January issue of Arthritis & Rheumatism. A possible link between diuretic use and gout was identified more than 25 years ago, but it has remained unclear whether the diuretic or the underlying hypertension is the main culprit. So DeMarco and colleagues analyzed data from the population-based Atherosclerosis Risk in Communities studies, focusing on 5,789 participants with hypertension, but not gout, at baseline. Men represented 42% of the cohort and African-Americans 31%. Mean age at the time of enrollment was 55, and mean body mass index was 29. A total of 37% of participants used diuretics during nine years of follow-up. The cumulative incidence of gout overall was 3.9%, but was higher in men than in women (5.3% versus 2.8%). The cumulative incidence of gout was significantly higher among those taking diuretics than among those not taking the drugs (5.5% versus 2.9%, P<0.001), the researchers reported. Any diuretic use also was associated with a three-fold higher risk of gout compared with untreated hypertension (HR 3.35, 95% CI 2.49 to 4.51). The risk of gout was elevated with both thiazide (HR 1.44, 95% CI 1 to 2.10) and loop (HR 2.31, 95% CI 1.36 to 3.91) diuretics, they noted. A total of 63 patients on thiazide diuretics developed gout, which represented a cumulative incidence of 5%; 23 cases occurred with loop diuretics, for an incidence of 7%. However, once again the association was lost after adjustment for serum urate levels for both thiazide (HR 0.94, 95% CI 0.64 to 1.38) and loop (HR 1.35, 95% CI 0.78 to 2.34) diuretics. In contrast to diuretics, treatment with other types of antihypertensive decreased the risk of gout (HR 0.64, 95% CI 0.49 to 0.86), and the risk was unchanged after adjustment for urate levels. Among patients who began diuretic treatment after enrollment in the study, serum urate levels were 0.72 mg/dL higher than in patients not taking the drugs, while initiation of a nondiuretic antihypertensive led to a decrease of 0.21 mg/dL. "Future studies should not only confirm the risk of gout associated with diuretic-induced hyperuricemia but also further elucidate the complicated relationship of hypertension, diuretics, uric acid, and gout," DeMarco and colleagues stated. Limitations of the study included self-report of gout, possible selection bias or confounding by indication, and a lack of information on specific brands of medication.
This
work was supported by the National Institutes of Health, the Donald B.
and Dorothy Stabler Foundation, and the Ira T. Fine Discovery Fund. The
authors reported no relationships with industry.
|
|||||||||
WSJournal Column Reviews New Wireless Glucometer.
On the front of its Personal Journal section, the Wall Street Journal 
(1/5, D1, Mossberg, Subscription Publication) reviews in its "Personal
Technology" column a new wireless glucometer for patients with
diabetes. Called the Telcare meter, the new device will not only
measure blood sugar, but will also transmit the readings to an
accessible database that can be read by patients, physicians and family
members. The device defaults to the T-Mobile network, but will shift
automatically to other networks if T-Mobile is not
available. Drawbacks are high price, poor battery life, and user
inability to get test strips or the meter itself from pharmacies.
Instead, patients must buy the meter and its supplies directly from
Telcare.
FDA Announces Restrictions On Cephalosporin Use In Farm Animals.
The New York Times 
(1/5, A12, Harris, Subscription Publication) reports that the FDA
"announced on Wednesday that farmers and ranchers must restrict their
use of a critical class of antibiotics," cephalosporins, "in cattle,
pigs, chickens and turkeys because such practices may have contributed
to the growing threat in people of bacterial infections that are
resistant to treatment." The medicines "are among the most common
antibiotics prescribed to treat pneumonia, strep throat, and skin and
urinary tract infections." Michael R. Taylor,
deputy commissioner for foods at the FDA, said, "We believe this is an
imperative step in preserving the effectiveness of this class of
important antimicrobials that takes into account the need to protect the
health of both humans and animals."
The AP 
(1/5, Jalonick) reports, "In a statement 
on the FDA website, the agency said the announcement is 'among a
number of ongoing FDA activities and initiatives intended to address
concerns about the use of antimicrobial drugs in animal agriculture.'"
These "include increased monitoring and voluntary guidelines for
producers on how to use the drugs judiciously."
The Wall Street Journal 
(1/5, Tomson, Subscription Publication) reports the FDA said that in
2010, US farm animals were given roughly 54,000 pounds of
cephalosporins, although altogether, the animals consumed more than 29
million pounds of antibiotics.
The Washington Post 
(1/5, Elboghdady) reports, "The antibiotics can no longer be used to
prevent diseases in livestock starting April 5, though they can still be
used to treat illnesses, the FDA said." Although "consumer advocates
support the FDA's decision," they contend that "the move is long overdue
and deals with only one small part of a much larger public health issue
tied to the overuse of antibiotics in animals."
The Chicago Tribune 
(1/5, Eng) reports that US Rep. Louise Slaughter (D-NY) said, "This is
a modest first step by the FDA," although "we're really just looking at
the tip of the iceberg. We don't have time for the FDA to ploddingly
take half-measures." According to Slaughter, "We are staring at a
massive public health threat in the rise of antibiotic-resistant
superbugs."
The Los Angeles Times 
(1/5, Brown) "Booster Shots" blog reports that Slaughter also said,
"With over 1 million Salmonella cases in the US each year, at least
30,000 Americans will contract cephalosporin-resistant bacteria every
year. I'm glad the FDA is finally acting but how many Americans have
needlessly been sickened in the meantime?"
CQ 
(1/5, Ethridge, Subscription Publication) reports, "American Academy of
Pediatrics President Robert Block also praised the decision, noting
that cephalosporin drugs are often used to treat several serious
childhood infections and have no warnings for pediatric use." According
to Block, "Pediatricians are already limited in the number and types of
antibiotics that we can use to treat ill children, and when one type of
antibiotic is found to be resistant to a strain of an infection, some
of our sickest young patients are left without
life-saving treatment options."
The National Journal 
(1/5, Fox, Subscription Publication) reports, "The comment period on
the new order closes on March 6." The agency "first proposed the rule
in 2008 and has been tweaking it ever since because of objections from a
range of groups."
Also covering the story are Bloomberg News 
(1/5, Peterson, Armour), the Lincoln (NE) Journal Star 
(1/5, Hovey), Reuters 
(1/5, Yukhananov), HealthDay 
(1/5, Preidt), and MedPage Today 
(1/5, Walker).
DASH Diet Ranked No. 1 By US News & World Report.
The Los Angeles Times 
(1/4, Stein) reported that the Dietary Approaches to Stop Hypertension
(DASH) "diet took the No. 1 spot in best overall diet in the US News
& World Report's Best Diets 2012, which also rates other popular
diets in various categories." The DASH diet "also took top ranking as
the best diet for healthy eating and the best diabetes diet (tied with
the Biggest Loser diet)." In addition, the DASH diet "may also help
lower cholesterol, as it's big on whole grains,
fruits, vegetables and lean proteins -- not a bad program for a number
of people."
NIH Diet Ranked 2nd Best Overall By US World & News Report.
WebMD 
(1/5, Doheny) reports that "the US News & World Report's Best
Diets 2012, a rating of 25 different diet plans," rated "Therapeutic
Lifestyle Changes (TLC), a diet that's high in fiber and low in fat,
developed by the National Institutes of Health," in second place "in the
best diets overall category." The ratings 
may be viewed online.
More on the DASH Diet:
Subscribe to:
Posts (Atom)